Reports

Ideas That Generate Results

List of Figures:

Figure 3-1: Global - Protein Therapeutics vs Pharmaceutical Market (Billion US$), 2014
Figure 3-2: Global - Protein Therapeutics Market (Billion US$), 2013-2020
Figure 3-3: Global - Protein Therapeutics Market by Segment (%), 2014
Figure 3-4: Global - Forecast for Protein Therapeutics Market by Segment (%), 2020
Figure 4-1: Global - Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-2: Global - Monoclonal Antibodies Market by Application (%), 2014
Figure 4-3: Global - Monoclonal Antibodies Application in Cancer Treatment (Billion US$), 2013-2020
Figure 4-4: Global - Monoclonal Antibodies Application in Rheumatoid Arthritis Treatment (Billion US$), 2013-2020
Figure 4-5: Global - Monoclonal Antibodies Application in Other Chronic Diseases Treatment (Billion US$), 2013-2020
Figure 4-6: US - Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-7: Europe - Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-8: Japan - Monoclonal Antibodies Market (Billion US$), 2013-2020
Figure 4-9: Global - Monoclonal Antibody Market by Key Players (%) (2014)
Figure 4-10: Global - Erythropoietin Market (Billion US$), 2012-2018
Figure 4-11: Global - Erythropoietin Market by Segment (%) (2014)
Figure 4-12: Global - Number of Patients on Dialysis (Million), 2014 & 2020
Figure 4-13: Global - Breakup of Patients on Dialysis by Region (%), 2014
Figure 4-14: Global - Number of New Cancer Cases (Million), 2012 & 2020
Figure 4-15: Global - Breakup of New Cancer Cases by Region (%), 2020
Figure 4-16: US - Erythropoietin Market (Billion US$), 2013-2020
Figure 4-17: Europe - Erythropoietin Market (Billion US$), 2013-2020
Figure 4-18: Global - Erythropoietin Market by Key Player (%), (2014)
Figure 4-19: Global - Insulin Market (Billion US$), 2013-2020
Figure 4-20: Global - Number of Diabetic Patients (Million), 2013 & 2035
Figure 4-21: US - Insulin Market (Billion US$), 2013-2020
Figure 4-22: Europe - Insulin Market (Billion US$), 2013-2020
Figure 4-23: Asia - Insulin Market (Billion US$), 2013-2020
Figure 4-24: Global - Insulin Market by Key Players (%) (2014)
Figure 4-25: Global - Insulin Market by Products (%)(2014)
Figure 4-26: Global - Interferon Market (Billion US$), 2013-2020
Figure 4-27: Global - Interferon Market by Segment (%) (2014)
Figure 4-28: Global - Interferon Alpha Market (Billion US$), 2012-2014
Figure 4-29: Global - Interferon Beta Market (Billion US$), 2012-2014
Figure 4-30: US - Interferon Market (Billion US$), 2013-2020
Figure 4-31: Europe - Interferon Market (Billion US$), 2013-2020
Figure 4-32: Global - Interferon Market by Key Player (%) (2014)
Figure 4-33: Global - Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-34: US - Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-35: Europe - Human Growth Hormone Market (Billion US$), 2013-2020
Figure 4-36: Global - Human Growth Hormone Market by Key Players (%) (2014)
Figure 4-37: Global - Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-38: Global - Blood Clotting Factor Market by Segment (%) (2014)
Figure 4-39: Global - Blood Clotting Recombinant Factor VIII Market (Billion US$), 2013-2020
Figure 4-40: Global - Recombinant Blood Clotting Factor VII Market (Billion US$), 2013-2020
Figure 4-41: Global - Recombinant Blood Clotting Factor Market IX (Billion US$), 2013-2020
Figure 4-42: US - Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-43: Europe - Blood Clotting Factor Market (Billion US$), 2013-2020
Figure 4-44: Global - Blood Clotting Factor Market by Key Players (%) (2014)
Figure 4-45: Global - Follicle Stimulating Hormone Market (Billion US$), 2013-2020
Figure 4-46: Global - Granulocyte Colony Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-47: US - Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 4-48: Europe - Granulocyte Colony-Stimulating Factor Market (Billion US$), 2013-2020
Figure 7-1: Porters Five Forces Analysis

List of Tables:

Table 3-1: US & Europe - Major Drugs Patent Expiry in Protein Therapeutics Market
Table 4-1: Global - Key Players and Drugs in Monoclonal Antibody Market (Billion US$), 2012-2014
Table 4-2: Global - Key Players and Drugs in Erythropoietin Alfa Market (Billion US$), 2012-2014
Table 4-3: Global - Key Players and Drugs in Erythropoietin Beta Market (Billion US$), 2012-2014
Table 4-4: Global - Key Players and Drugs in Darbepoetin Market (Billion US$), 2012-2014
Table 4-5: US - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035f
Table 4-6: Europe - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035
Table 4-7: China - Diabetic Patients in Age Group 20-79 Years ('000), 2013 & 2035f
Table 4-8: Global - Key Players and Drugs in Interferon Alpha Market (Billion US$), 2012-2014
Table 4-9: Global - Key Players and Drugs in Interferon Beta Market (Billion US$), 2012-2014
Table 4-10: Global - Key Players and Drugs in Human Growth Hormone Market (Billion US$), 2012-2014
Table 4-11: Global - Key Players and Drugs in Blood Clotting Factor Market (Billion US$), 2012-2014
Table 4-12: Global - Key Players and Drugs in Follicle Stimulating Hormone Market (Billion US$), 2012-2014
Table 4-13: Global - Key Players and Drugs in Granulocyte Colony Stimulating Factor Market (Billion US$), 2012-2014
Table 5-1: Advanced Phase Protein Therapeutics
Table 8-1: Johnson & Johnson - Key Products in Protein Therapeutics
Table 8-2: Biogen - Key Products in Protein Therapeutics
Table 8-3: Eli Lilly - Key Products in Protein Therapeutics
Table 8-4: Sanofi-Aventis - Key Products in Protein Therapeutics
Table 8-5: Merck Serono - Key Products in Protein Therapeutics
Table 8-6: Roche - Key Products in Protein Therapeutics
Table 8-7: Amgen Inc. - Key Products in Protein Therapeutics
Table 8-8: Pfizer Inc. - Key Products in Protein Therapeutics
Table 8-9: Abbott Laboratories - Key Products in Protein Therapeutics
Table 8-10: Novo Nordisk - Key Products in Protein Therapeutics